austin

Best Peptides for Muscle Growth: Prescription Sermorelin Access, Injectable vs. Dissolving Tablets, and Realistic Expectations

AUSTIN, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only. It is not medical advice.…

2 weeks ago

Xojo 2025r3 Delivers Major Updates, New Libraries Feature, Integrated AI Assistant, and Modern OS Support

AUSTIN, Texas, Dec. 16, 2025 /PRNewswire/ -- Xojo, Inc., the developers behind Xojo—a powerful cross-platform development tool and programming language—…

3 weeks ago

SkyFi Selected for NATO DIANA 2026 Defense Innovation Accelerator

Earth Intelligence Platform Selected to Advance Dual-Use AI Technology for Alliance Security and ResilienceAUSTIN, Texas, Dec. 11, 2025 /PRNewswire/ -- SkyFi,…

4 weeks ago

Texan Artisinal Review: Context, Accuracy & Risk in NYC of Bisnow’s Real-Estate Reporting

Austin, Texas, Nov. 21, 2025 (GLOBE NEWSWIRE) -- In the fast-moving landscape of New York City commercial real estate, the…

2 months ago

Crypto Mondays Austin Presents: Regenerative Wealth Where Blockchain, Wellness, Fashion, and Human Potential Meet

Austin, TX, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Crypto Mondays Austin announces Regenerative Wealth, an innovative gathering that merges technology,…

2 months ago

ROLLER Doubles Down on Industry Intelligence with ROLLER iQ and the 2026 Attractions Industry Benchmark Report

New capabilities in ROLLER iQ and the 2026 Attractions Industry Benchmark Report provide operators with richer benchmarking data than ever…

2 months ago

ROLLER Introduces ROLLER iQ, the AI Assistant Built for the Attractions Industry

As part of ROLLER's November 2025 Product Launch, ROLLER iQ introduces a new era of intelligence for attractions, transforming real-time…

2 months ago

SEON Showcases AI-Powered Fraud Prevention and AML Innovations at Singapore FinTech Festival 2025; Company Executive to Present on Collaborative Cyber Resilience

SINGAPORE and AUSTIN, Texas, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SEON, the command center for fraud prevention and compliance, today…

2 months ago

ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium

Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, announced analyses data…

2 months ago

IBM and Mission 44 Join Forces to Fast-Track AI Skills

New multi-year collaboration launches in Austin ahead of the 2025 Formula 1 United States Grand Prix to promote STEM career…

3 months ago